LOS ANGELES, Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. ("Neumora" or "the Company") (NASDAQ: NMRA) for violations of the federal securities laws....
Read More Details
Finally We wish PressBee provided you with enough information of ( NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm )
Also on site :
- Beloved brand ends controversial 50 cent fee on popular breakfast staple as it gets ahead of Waffle House
- Russia’s international reserves hit all-time high – central bank
- Rihanna and ASAP Rocky's Son RZA, 3, Studies French on Family Road Trip